# IITRI - PERFORMANCE AREA 1 TO2

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2024 · $82,128

## Abstract

The National Institute on Neurological Disorders and Stroke (NINDS) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts are assessing the pharmacokinetics, toxicology and safety of promising compounds to support their eventual use as therapeutics Under the NIH Blueprint Neurotherapeutics Network (BPN), the Pharmacology and Toxicology for Therapeutics Program (PTTP) provides a critical component of the BPN drug development infrastructure. PTTP supports all preclinical pharmacology and toxicology testing needed to inform lead discovery and the selection of a clinical candidate, as well as comprehensive studies needed for regulatory filings such as FDA Investigational New Drug (IND) applications to allow for clinical evaluation of the candidates.  This task
order covers the Performance Area 1 which include the management and operations support of the IDIQ contract and task orders.

## Key facts

- **NIH application ID:** 11211345
- **Project number:** 75N95021D00026-0-759502400001-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** MICHAEL O'RYAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $82,128
- **Award type:** —
- **Project period:** 2024-03-01 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11211345

## Citation

> US National Institutes of Health, RePORTER application 11211345, IITRI - PERFORMANCE AREA 1 TO2 (75N95021D00026-0-759502400001-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11211345. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*